
Injective (INJ) is trading at a decisive level after the $11.8–$12.0 area shifted from support into resistance. The token was priced at $11.81, which represents a 1.5% decrease during the last 24 hours. INJ is valued at 0.0001038 BTC compared to Bitcoin and 0.002826 ETH compared to Ethereum, respectively. Such a match in terms of levels underlines the significance of the present retest when the market considers its further course of action.
The $11.8–$12.0 zone, once a consistent base, has now flipped into resistance. This development emphasizes a structural change that places immediate pressure on the asset. In the $11.75 range, the buyers persist in holding the floor and maintain the market at balance within the range of $11.75 and $12.22. Interestingly, the range has narrowed down to even smaller values over the last few sessions, which indicates reduced volatility and the emphasis on the breakout levels.
If the market manages to reclaim and hold above the $12.0 threshold, the structure opens space toward higher levels. Data indicates that such movement would likely enable testing of $13.0, with potential extension toward $14.0 and beyond.
However, failure to break higher leaves the downside vulnerable. Importantly, a sustained decline beneath $11.5 would expose the asset to the broader $10.2–$10.8 demand zone, which previously attracted strong buying activity.
The chart structure illustrates the importance of the ongoing retest, with the price consolidating below resistance. The balance between short-term support and overhead resistance keeps the market in anticipation of a decisive move. Notably, both upward and downward outcomes remain possible depending on how price reacts to the current zone. With trading volume at 365.71K, activity continues to track closely to these boundaries, shaping short-term expectations.